NCT04312360View on ClinicalTrials.gov

Preoperative Endoscopic Treatment With Fosfomycin and Metronidazole in Patients With Right-sided Colon Cancer and Colon Adenoma (MEFO-trial)

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 16, 2020

Primary Completion Date

April 13, 2022

Study Completion Date

July 1, 2023

Conditions
Right-sided Colon CancerRight-sided Colon Adenoma
Interventions
DRUG

therapeutic endoscopy with metronidazole and fosfomycin disodium

therapeutic endoscopy where the two drugs: metronidazole and fosfomycin disodium are sprayed through out the right colon section (from caecum to right colon flexure). This intervention is going to be performed on patients in both track 1 and track 2a.

Trial Locations (2)

2730

Department of Surgery, Herlev Hospital, Copenhagen

4200

Department of Surgery, Zealand University Hospital, Køge

All Listed Sponsors
collaborator

Costerton Biofilm Center

UNKNOWN

collaborator

Reponex Pharmaceuticals A/S

INDUSTRY

collaborator

Region Zealand

OTHER

lead

Zealand University Hospital

OTHER

NCT04312360 - Preoperative Endoscopic Treatment With Fosfomycin and Metronidazole in Patients With Right-sided Colon Cancer and Colon Adenoma (MEFO-trial) | Biotech Hunter | Biotech Hunter